Clinical Trials on Skin Irritation

Total 50144 results

Eli Lilly and Company

Terminated

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Psoriasis

United States, Spain, Puerto Rico, Canada, France, Korea, Republic of, Germany, Australia, Italy, Israel, Poland, Japan, Argentina, Hungary, Taiwan, United Kingdom, Mexico, Czechia, Russian Federation
Bristol-Myers Squibb

Completed

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis (POETYK-PSO-1)

Psoriasis

China, Korea, Republic of, Spain, United States, United Kingdom, Canada, Russian Federation, Japan, Germany, Poland, Taiwan
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Active, not recruiting

A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Psoriasis

China
Centre Hospitalier Universitaire de Nīmes

Completed

Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis (PSORTI-BIO)

Psoriasis

France
Paracrine Therapeutics Dermatology Pte. Ltd.
National University Hospital, Singapore

Completed

Safety and Tolerability Study of MSC Exosome Ointment

Psoriasis

Singapore
Boehringer Ingelheim

Completed

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

Psoriasis

United States, Canada, Germany
Bausch Health Americas, Inc.

Completed

A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Psoriasis

Canada
South Valley University

Active, not recruiting

Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .

Psoriasis

Egypt
Alvotech Swiss AG
Iqvia Pty Ltd

Completed

Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)

Psoriasis

Australia, New Zealand
HaEmek Medical Center, Israel

Completed

The Inner Ear Function in Psoriatic Patients (MP)

Psoriasis

Israel
BioFactura Australia Pty Ltd.
Avance Clinical Pty Ltd.

Completed

Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults

Psoriasis

Australia, New Zealand
Incyte Corporation

Completed

A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Psoriasis

United States
University Hospital, Toulouse

Completed

Therapeutic Education Program in Psoriasis (EDUPSO)

Psoriasis

France
Affibody

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2

Psoriasis

United States
AbbVie

Completed

A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China (ADAPT)

Psoriasis

China
Bio-Thera Solutions

Completed

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

Psoriasis

China
Dermira, Inc.

Completed

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Psoriasis

Canada
Second Affiliated Hospital, School of Medicine,...

Unknown

The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases

Inflammatory Skin Disease

China
AstraZeneca

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis

Psoriasis

Australia, New Zealand
Icahn School of Medicine at Mount Sinai

Completed

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Psoriasis

United States
Guangdong Provincial Hospital of Traditional Chinese...

Unknown

Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis

Psoriasis

China
Rockefeller University
Genentech, Inc.

Completed

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
University of Pennsylvania
Pfizer

Completed

Psoriasis Microbiome and Phototherapy

Psoriasis

United States
Boston Pharmaceuticals

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis

Psoriasis

Australia
Akesobio Australia Pty Ltd

Completed

A Study of AK111 in Healthy Subjects

Psoriasis

New Zealand
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Psoriasis

United States
Eli Lilly and Company

Completed

A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris

Psoriasis

China
GlaxoSmithKline

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

Psoriasis

Canada
University of California, San Francisco

Terminated

Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis (Photos)

Psoriasis

United States
Celgene

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Psoriasis

United States, Canada
Amgen

Completed

A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium (OTELO)

Psoriasis

Belgium
AbbVie

Completed

Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab (RAPSODI)

Psoriasis

Korea, Republic of
Bristol-Myers Squibb

Completed

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey
Janssen Scientific Affairs, LLC

Completed

An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

Psoriasis

United States
University of Michigan
AbbVie

Completed

Skin Tape Harvesting for Transcriptomics Analysis

Psoriasis

United States
Janssen-Cilag G.m.b.H

Completed

A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (POLARIS)

Psoriasis

Germany
Bausch Health Americas, Inc.

Terminated

Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects (AMAGINE-1)

Psoriasis

United States, Germany, Poland, Switzerland, France, Canada
AbbVie (prior sponsor, Abbott)
Cato Research; JSS Medical Research Inc.

Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis (Complete-PS)

Psoriasis

Canada
Eli Lilly and Company

Completed

A Study in Japanese Participants With Moderate-to-Severe Psoriasis (UNCOVER-J)

Psoriasis

Japan
Zagazig University

Unknown

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

Psoriasis
Bausch Health Americas, Inc.

Terminated

Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Psoriasis

United States, Australia, France, Canada, Denmark
Amgen

Completed

Etanercept (Enbrel®) in Psoriasis - Pediatrics

Psoriasis
Cairo University

Unknown

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

Psoriasis
Amgen

Completed

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Psoriasis

Australia, Canada, Hungary
Assiut University

Unknown

Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis

Psoriasis
Eli Lilly and Company

Completed

A Study of Ixekizumab in Participants With Plaque Psoriasis

Psoriasis

United States
Janssen Biotech, Inc.

Completed

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

Psoriasis
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)

Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate

Completed

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Psoriasis

United States
Janssen Research & Development, LLC

Completed

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Psoriasis

United States, Canada, Poland

3

Subscribe